Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
Eli Lilly Stock Could Have a Huge Growth Catalyst in Early 2025
Motley Fool
Thu, 12/12/24 - 11:41 pm
Eli Lilly
orforglipron
Eli Lilly is going to test Zepbound as a treatment for addiction
Quartz
Wed, 12/11/24 - 10:44 pm
Eli Lilly
David Ricks
Zepbound
addiction
alcohol-use disorder
Lilly to offer single-dose vials of weight-loss drug on telehealth platform Ro
Yahoo Finance
Wed, 12/11/24 - 11:01 am
Eli Lilly
Ro
telehealth
Zepbound
Lilly CEO says tax and regulation reform, drug affordability are focuses under Trump
MSN/Reuters
Tue, 12/10/24 - 09:58 pm
Eli Lilly
David Ricks
Pharma CEOs
Donald Trump
taxes
regulatory
ASH: Eli Lilly touts novel BTK trial win for Jaypirca as execs defend survival data blemish
Fierce Pharma
Tue, 12/10/24 - 11:10 am
ASH 2024
Eli Lilly
Jaypirca
CLL
Trump, RFK Jr. dine with Pfizer and Lilly execs
Axios
Sun, 12/8/24 - 09:55 pm
Donald Trump
Pfizer
Eli Lilly
PhRMA
Robert F Kennedy Jr.
cancer
On an investment spree, Lilly will spend $3B to expand newly acquired injectables plant in Wisconsin
Fierce Pharma
Thu, 12/5/24 - 04:19 pm
Eli Lilly
Wisconsin
drug manufacturing
For first phase of Mounjaro's obesity rollout in England, only a limited number of patients will have access
Fierce Pharma
Wed, 12/4/24 - 11:05 pm
Eli Lilly
Mounjaro
obesity
England
Lilly’s Zepbound beats Novo’s Wegovy in high-stakes obesity drug trial
BioPharma Dive
Wed, 12/4/24 - 11:02 am
Eli Lilly
Zepbound
Novo Nordisk
Wegovy
clinical trials
weight loss
obesity
Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
Pharma Live
Tue, 12/3/24 - 11:36 am
Novo Nordisk
India
Wegovy
Eli Lilly
Zepbound
Four oral GLP-1R products in Phase III trials as race intensifies
Clinical Trials Arena
Tue, 12/3/24 - 11:17 am
Novo Nordisk
Eli Lilly
Jiangsu Hengrui
GLP-1R
GLP-1 agonists
clinical trials
Why Amgen's Weight Loss Result Is a Win for Eli Lilly
Motley Fool
Wed, 11/27/24 - 11:30 am
Amgen
MariTide
Eli Lilly
Zepbound
Biden proposes Medicare and Medicaid cover weight loss drugs
Axios
Tue, 11/26/24 - 09:51 am
Joe Biden
Medicare
Medicaid
obesity
Novo Nordisk
Eli Lilly
Zepbound
Wegovy
Ozempic
Pfizer led industrywide sales surge in Q3 after several quarters of dominance by Eli Lilly, Novo Nordisk
Fierce Pharma
Mon, 11/25/24 - 11:43 am
Pfizer
earnings
Eli Lilly
Novo Nordisk
Drugmakers and pharmacists battle over who gets to make obesity drugs
NPR
Wed, 11/20/24 - 11:21 am
Novo Nordisk
Eli Lilly
obesity
weight loss
GLP-1 agonists
compounded drugs
Lilly's lipoprotein-blocking heart med posts midstage win, turning up heat on potential AZ showdown
Fierce Biotech
Tue, 11/19/24 - 11:16 am
Eli Lilly
lipoproteins
clinical trials
cholesterol
muvalaplin
New Alzheimer's prevention trial receives $74.5 million NIH grant
Drugs.com
Sun, 11/17/24 - 09:22 pm
Eli Lilly
Alzheimer's disease
NIH
clinical trials
Survey Finds Most GLP-1 Users Discontinue Drug Before Reaching Goal Weight
Xtalks
Fri, 11/15/24 - 11:27 am
Omada Health
GLP-1 agonists
obesity
weight loss
Novo Nordisk
Eli Lilly
Ozempic
Zepbound
Mounjaro
Wegovy
Lilly sues US agency over blocking of drug-rebate program
MSN/Reuters
Fri, 11/15/24 - 11:08 am
Eli Lilly
340B
HRSA
drug rebates
legal
Eli Lilly’s weight-loss drug helps nearly 99% of patients remain diabetes-free
Pharma Live
Thu, 11/14/24 - 11:21 am
Eli Lilly
weight loss
tirzepatide
Mounjaro
Zepbound
diabetes
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »